TerminatedPhase 4ACTRN12610000235000

Impact of topical lignocaine on the incidence of perioperative respiratory complications in children undergoing laryngo-tracheo-bronchoscopies – a double blind randomised controlled pilot study

Sponsor

Prof Britta Regli-von Ungern-Sternberg

Enrollment

200 participants

Start Date

Nov 18, 2009

Study Type

Interventional

Conditions

Respiratory complications following topical lignocaine onto the vocal cords for laryngotracheobronchoscopies

Summary

the purpose of this study is to characterize the modification induced by lignocaine on the incidence of intraoperative and postoperative respiratory complications in children undergoing laryngo tracheo bronchoscopies.

Eligibility

Sex: Both males and femalesMax Age: 16 Yearss

Plain Language Summary

Simplified for easier understanding

This study tests whether applying a numbing medication (lignocaine) to the airway during a breathing tube examination can reduce breathing complications in children aged 0 to 16 who need this procedure. The goal is to make the procedure safer with fewer side effects like coughing or throat spasms.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Topical lignocaine vs. placebo onto vocal cords for a laryngo-tracheo-bronchoscopy. The lignocaine is applied directly following induction of anaesthesia. It is only applied once which takes one spra

Topical lignocaine vs. placebo onto vocal cords for a laryngo-tracheo-bronchoscopy. The lignocaine is applied directly following induction of anaesthesia. It is only applied once which takes one spray of lignocaine of 5-10 seconds duration. The lignocaine dose used will be a maximum of 4 mg/kg as topical spray (under vision) onto the vocal cords. For this trial, lignocaine 4% will be used in all children. In children > 30 kg 3 ml of lignocaine 4% will be applied.

Locations(1)

Princess Margaret Hospital - Subiaco

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12610000235000